前11月97%普通股基上涨 易方达战略新兴产业涨九成

Core Viewpoint - The performance of ordinary stock funds in China has been predominantly positive in 2023, with 97% of comparable funds reporting gains, largely driven by the semiconductor sector's strong performance. Group 1: Fund Performance - As of November 30, 2023, out of 970 comparable ordinary stock funds, 941 funds achieved positive performance, representing a 97% success rate, while only 29 funds experienced declines [1] - The top-performing funds include E Fund Strategic Emerging Industries Stock A and C, both of which saw gains exceeding 90%, primarily due to the semiconductor sector's robust growth [1] - E Fund Information Industry Select Stock A ranked third with a 89.71% increase, benefiting from similar sector trends [1] Group 2: Fund Managers and Holdings - The fund manager of E Fund Strategic Emerging Industries, Ouyang Liangqi, has a background as an industry researcher and has been managing the fund since 2023 [1] - E Fund Information Industry Select Stock A's manager, Zheng Xi, has 13 years of management experience and oversees a portfolio heavily invested in semiconductor stocks [2] - The top holdings of these funds include major companies like Tencent, Alibaba, and various semiconductor firms, indicating a concentrated investment strategy in high-growth sectors [1][2] Group 3: Underperforming Funds - Only 14 ordinary stock funds reported declines exceeding 5% in the same period, with the largest losses seen in Taikang Medical Health Stock A and C, which fell by -10.56% and -10.14% respectively [3] - The underperforming funds primarily focused on healthcare and biopharmaceutical sectors, which have not matched the growth seen in technology and semiconductor sectors [3] - The cumulative returns of some underperforming funds, such as the Shenwan Lixin Medical Pioneer Stock, showed significant losses of up to 51.99% [3]